Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: Likelihood of recurrence on discontinuation after 6 months' remission

American Journal of Psychiatry

Volumn 154, Issue 1, 1997, Pages 31-36

  Stewart, Jonathan W ^a,b   Tricamo, Elaine ^a   McGrath, Patrick J ^a   Quitkin, Frederic M ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE; PHENELZINE; PLACEBO;

ADULT; ARTICLE; CHRONICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; FEMALE; HUMAN; MAINTENANCE THERAPY; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RATING SCALE; RECURRENCE RISK; SURVIVAL RATE;

EID: 0031032747     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.1.31     Document Type: Article

References (27)

1. Bielski RJ, Friedel RO: Prediction of tricyclic antidepressant response: a critical review. Arch Gen Psychiatry 1976; 33:1479-1489
2. Joyce PR, Paykel ES: Predictors of drug response in depression. Arch Gen Psychiatry 1989; 46:89-99
3. Montgomery SA, Montgomery DB: Prophylactic treatment in recurrent unipolar depression, in Long-Term Treatment of Depression. Edited by Montgomery SA, Rouillon F. New York, John Wiley & Sons, 1992, pp 53-79
4. Fava M, Kaji J: Continuation and maintenance treatments of major depressive disorder. Psychiatr Annals 1994; 24:281-290
5. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM: Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991; 48:851-855
6. Prien RF, Klett CJ, Caffey EM: Lithium carbonate and imipramine in prevention of affective episodes: a comparison in recurrent affective illness. Arch Gen Psychiatry 1973; 29:420-425
7. Prien RF, Kupfer DJ, Mansky PA, Small JG, Tuason VB, Voss CB, Johnson WE: Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders: report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 1984; 41:1096-1104
8. Coppen A, Ghose K, Montgomery S, Rama Rao VA, Bailey J, Jorgensen A: Continuation therapy with amitriptyline in depression. Br J Psychiatry 1978; 133:28-33
9. Frank E, Kupfer DJ, Perel JM, Cornes C, Jarrett DB, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ: Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990; 47:1093-1099
10. Georgotis A, McCue RE, Cooper TB: A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch Gen Psychiatry 1989; 46: 783-786
11. Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard A: Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlied comparison. Arch Gen Psychiatry 1982; 39:1065-1069
12. Glen AIM, Johnson AL, Shepherd M: Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized, double-blind, controlled trial. Psychol Med 1984; 14: 37-50
13. Stewart JW, McGrath PJ, Rabkin JG, Quitkin FM: Atypical depression: a valid clinical entity? Psychiatr Clin North Am 1993; 16:479-496
14. Robinson DS, Lerfald SC, Bennett B, Laux D, Devereaux E, Kayser A, Corcella J, Alhright D: Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study. Psychopharmacol Bull 1991; 27:31-39
15. Harrison W, Rabkin J, Stewart JW, McGrath PJ, Tricamo E, Quitkin F: Phenelzine for chronic depression: a study of continuation treatment. J Clin Psychiatry 1986; 47:346-349
16. Regier DA, Boyd JH, Burke JD Jr, Rae DS, Myers JK, Kramer M, Robins LN, George LK, Karno M, Locke BZ: One-month prevalence of mental disorders in the United States: based on five Epidemiologic Catchment Area sites. Arch Gen Psychiatry 1988; 45: 977-986
17. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, McGlynn EA, Ware JE: Functional status and well-being of patients with chronic conditions: results from the Medical Out-come Study. JAMA 1989; 262:907-913
18. Johnson J, Weissman MM, Klerman GL: Service utilization and social morbidity associated with depressive symptoms in the community. JAMA 1992; 267:1478-1483
19. Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison WM, Markowitz JS, Rabkin JG, Tricamo E, Goetz DM, Klein DF: Antidepressant specificity in atypical depression. Arch Gen Psychiatry 1988; 45:129-138
20. Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Tricamo E, Wager SG, Ocepek-Welikson K, Nunes E, Rabkin JG, Klein DF: Atypical depression, panic attacks, and response to imipramine and phenelzine: a replication. Arch Gen Psychiatry 1990; 47: 935-941
21. Quitkin FM, Stewart JW, McGrath PJ, Liebowitz MR, Harrison WM, Tricamo E, Klein DF, Rabkin JG, Markowitz JS, Wager SG: Phenelzine vs imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders. Am J Psychiatry 1988; 145:306-311
22. McGlashan T (ed): The Documentation of Clinical Psychotropic Drug Trials. Rockville, Md, National Institute of Mental Health, 1973
23. Spitzer RL, Williams JBW, Gibbon M: Structured Clinical Interview for DSM-III-R (SCID). New York, New York State Psychiatric Institute, Biometrics Research, 1985
24. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
25. Derogatis LR: SCL-90-R: Administration, Scoring, and Procedures Manual, I, for the Revised Version. Baltimore, Johns Hopkins University, Clinical Psychometrics Research Unit, 1977
26. Stewart JW, McGrath PJ, Quitkin FM, Harrison W, Markowitz J, Wager S, Liebowitz MR: Relevance of DSM-III depressive subtype and chronicity to antidepressant efficacy in atypical depression: differential response to phenelzine, imipramine, and placebo. Arch Gen Psychiatry 1989; 46:1080-1087
27. Agosti V, Stewart JW, Quitkin FM, Rabkin JG, McGrath PJ, Markowitz J: Factors associated with premature medication discontinuation among responders to an MAOI or a tricyclic antidepressant. J Clin Psychiatry 1988; 49:196-198